Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 21 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (2)
P 1 (1)
P 3 (1)

Trial Status

Unknown7
Completed5
Recruiting5
Active Not Recruiting4

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT06140823Active Not RecruitingPrimary

Prospective Validation of Liver Cancer Risk Computation (LIRIC) Models

NCT05973331Active Not Recruiting

Prospective Validation of an EHR-based Pancreatic Cancer Risk Model

NCT06364371RecruitingPrimary

Dynamic Multi-omics Integration Model to Predict Neoadjuvant Therapy Response in Locally Advanced Rectal Cancer

NCT06023966CompletedPrimary

A Clinical Prospective Study to Validate a Risk Scoring Model for the HMGC After Curative Surgery

NCT06339307CompletedPrimary

A Prospective Clinical Study to Validate a Preoperative Risk Scoring Model for LNM in GC Patients

NCT05741944Not ApplicableActive Not Recruiting

The Value of a Risk Prediction Tool (PERSARC) for Effective Treatment Decisions of Soft-tissue Sarcomas Patients

NCT06411015CompletedPrimary

Prognostic Evaluation Prediction Model Survival Spinal Epidural Metastases

NCT06391892Phase 3Recruiting

Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery

NCT06202404Recruiting

Predicting Tumor Metastasis by Employing a Target Organ/Primary Lesion Fusion Radiomics Model

NCT06074029Phase 1Active Not Recruiting

Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy

NCT06092918CompletedPrimary

Generation and Validation of Predictive Models for Localized Prostate Cancer Treated With External Radiotherapy.

NCT03253107Unknown

Predicting Biomarker of Gastric Cancer Chemotherapy Response

NCT05997147UnknownPrimary

A Preoperative Model to Predict the Lymphovascular Invasion in Pancreatic Ductal Adenocarcinoma

NCT05929365RecruitingPrimary

Innovative Approach to Detect Recurrent Colorectal Lesions With Surveillance Via Mutation Analysis & Clinical Phenotype

NCT05338073Unknown

KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models

NCT04185779Recruiting

COLO-COHORT (Colorectal Cancer Cohort) Study

NCT04535466Unknown

Diagnosis Predictive Modle for Dense Density Breast Tissue Based on Radiomics

NCT04511481UnknownPrimary

Deep Learning Magnetic Resonance Imaging Radiomic Predict Platinum-sensitive in Patients With Epithelial Ovarian Cancer

NCT04452058UnknownPrimary

CT-based Radiomic Algorithm for Assisting Surgery Decision and Predicting Immunotherapy Response of NSCLC

NCT04079283Completed

Radiomics of Immunotherapeutics Response Evaluation and Prediction

Scroll to load more

Research Network

Activity Timeline